ANB Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.06M Sell
1,780
-90
-5% -$106K 0.73% 34
2026
Q2
$2.24M Sell
1,870
-116
-6% -$119K 0.84% 29
2026
Q1
$1.83M Sell
1,986
-85
-4% -$86.2K 0.74% 34
2025
Q4
$2.23M Sell
2,071
-49
-2% -$46.9K 0.88% 30
2025
Q3
$1.62M Buy
2,120
+183
+9% +$136K 0.66% 39
2025
Q2
$1.51M Buy
1,937
+20
+1% +$15.5K 0.68% 41
2025
Q1
$1.58M Buy
1,917
+2
+0.1% +$1.66K 0.71% 39
2024
Q4
$1.48M Buy
+1,915
New +$1.59M 0.65% 43

Other funds holding LLY

ANB Bank's LLY Position: Q3 2026 in Review

ANB Bank reduced its Eli Lilly (LLY) stake by 4.8% in Q3 2026, selling an estimated $106K and leaving 1,780 shares worth $2.06M. The position accounts for 0.73% of the portfolio, ranked #34.

ANB Bank first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.24M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • ANB Bank held 1,780 shares of Eli Lilly worth $2.06M as of Q3 2026.
  • ANB Bank sold 90 Eli Lilly shares in Q3 2026, an estimated $106K.
  • Eli Lilly made up 0.73% of ANB Bank's portfolio in Q3 2026, its #34 holding.
  • ANB Bank first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • ANB Bank's Eli Lilly position peaked at $2.24M in Q2 2026.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on ANB Bank's 13F filing for Q3 2026, filed 9 Oct 2026.